%PDF-1.4
%
77 0 obj
<>
endobj
74 0 obj
<>
endobj
141 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-12-02T16:12:26Z
2024-03-28T03:29-07:00
QuarkXPressª: AdobePS 8.6 (219)
2024-03-28T03:29-07:00
application/pdf
Heather
201178.dec
uuid:e0165754-1dd1-11b2-0a00-6309277d8900
uuid:e0165757-1dd1-11b2-0a00-d30000000000
endstream
endobj
63 0 obj
<>
endobj
64 0 obj
<>
endobj
78 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
4 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
22 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
45 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
48 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
51 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
167 0 obj
[172 0 R]
endobj
168 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
/CS0 CS 0 0 0 1 SCN
/GS1 gs
54 54 m
558 54 l
S
BT
/CS0 cs 0 0 0 1 scn
/TT0 1 Tf
0.02499 Tw 8 0 0 8 420.3613 35.9844 Tm
(The Journal of Rheumatology 2001; 28:12)Tj
0 Tw -45.7952 -0.0313 Td
(2680)Tj
ET
0 0 0 0 scn
/GS0 gs
103.25 59.08 407.5 -10.83 re
f*
0.5 w
103.25 59.08 407.5 -10.83 re
S
BT
0 0 0 1 scn
/GS1 gs
/TT1 1 Tf
0.02499 Tw 7.76 0 0 8 72 714.5293 Tm
(subcutaneous air pouch. Clin Exp Rheumatol 1985;3:291-6.)Tj
-0.00011 Tc -1.817 -1.275 Td
[(18.)-567 (Shin )37 (YM, Sidgwick )55 (AD, Moore )55 (A, )18 (W)40 (illoughby DA. Studies on the)]TJ
0 Tc 1.817 -1.275 Td
(clearance of calcium pyrophosphate crystals from facsimile synovium.)Tj
0 -1.275 TD
(Ann Rheum Dis 1984;43:487-92.)Tj
-1.817 -1.25 Td
[(19.)-567 (W)80 (atanabe )18 (W)92 (, Baker DG, Schumacher HR Jr)55 (. Comparison of the acute)]TJ
1.817 -1.25 Td
(inflammation induced by calcium pyrophosphate dihydrate, apatite)Tj
0 -1.25 TD
(and mixed crystals in the rat air pouch model of a synovial space. )Tj
T*
(J Rheumatol 1992;19:1453-7.)Tj
-0.00011 Tc -1.817 -1.25 Td
[(20.)-567 (Hamanishi C. Blood-synovial barrier)55 (. Seikeigeka MOOK 1984;)]TJ
0 Tc 0 Tw 1.817 -1.25 Td
(32:58-70.)Tj
-0.00011 Tc 0.02499 Tw -1.817 -1.25 Td
[(21.)-567 (T)70 (erkeltaub R, Dyer CA, Martin J, Curtiss LK. )55 (Apolipoprotein \(Apo\) E)]TJ
0 Tc 1.817 -1.25 Td
(inhibits the capacity of monosodium urate crystals to stimulate)Tj
T*
(neutrophils. J Clin Invest 1991;87:20-6.)Tj
-0.00011 Tc -1.817 -1.25 Td
[(22.)-567 (T)70 (erkeltaub R, Martin J, Curtiss LK, Ginsber)18 (g MH.)]TJ
0 Tc 1.817 -1.25 Td
(Glycosaminoglycans alter the capacity of low density lipoprotein to)Tj
T*
[(bind to monosodium urate crystals. J Rheumatol 1990;17:121)37 (1-6.)]TJ
32.2036 18.825 Td
[(23.)-567 (Bonneau C, Couderc R, Roch-Arveiller M, Giroud JP)111 (, Raichvar)18 (g D.)]TJ
1.817 -1.25 Td
[(Ef)18 (fects of low-density lipoproteins on polymorphonuclear leukocyte)]TJ
T*
(functions in vitro. J Lipid Mediat Cell Signal 1994;10:203-12.)Tj
-0.00011 Tc -1.817 -1.25 Td
[(24.)-567 (Hui D )37 (Y)129 (, Harmony JAK, Innerarity )18 (TL, Mahley R)55 (W)92 (. Immuno)]TJ
0 Tc 1.817 -1.25 Td
(regulatory plasma lipoproteins \227 Role of apoprotein E and apoprotein)Tj
T*
[(B J Biol Chem 1980;255:1)37 (1775-81.)]TJ
-1.817 -1.25 Td
[(25.)-567 (Pepe MG, Curtiss LK. )55 (Apolipoprotein E is a biologically active)]TJ
1.817 -1.25 Td
(constituent of the normal immunoregulatory lipoprotein, LDL-In. )Tj
T*
(J Immunol 1986;136:3716-23.)Tj
-1.817 -1.25 Td
[(26.)-567 (Liote F)80 (, Prudhommeaux F)80 (, Schiltz C, et al. Inhibition and prevention)]TJ
1.817 -1.25 Td
(of monosodium urate monohydrate crystal-induced acute)Tj
T*
[(inflammation in vivo by transforming growth factor \3371. )55 (Arthritis)]TJ
T*
[(Rheum 1996;39:1)37 (192-8.)]TJ
-1.817 -1.25 Td
[(27.)-567 (Ortiz-Bravo E, Schumacher HR Jr)55 (. Components generated locally as)]TJ
1.817 -1.25 Td
[(well as serum alter the phlogistic ef)18 (fect of monosodium urate crystals)]TJ
T*
[(in vivo. J Rheumatol 1993;20:1)37 (162-6.)]TJ
ET
0 0 0 0 scn
468 770 90 -25 re
f*
Q
Q
q
0 0 612 792 re
W n
BT
0 g
ET
/GS2 gs
BT
/T1_0 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2001. All rights reserved.)Tj
ET
Q
BT
0 g
/GS3 gs
/T1_1 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS3 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS3 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
116 0 obj
<>
endobj
146 0 obj
<>
endobj
80 0 obj
<>
endobj
82 0 obj
<>
endobj
83 0 obj
<>
endobj
108 0 obj
<>stream
HtVpT <$ɮPH
K
a,KdML